Patents by Inventor Melissa Maxwell

Melissa Maxwell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CHEMICALLY MODIFIED OLIGONUCLEOTIDES
    Publication number: 20240301430
    Abstract: The disclosure relates, in some aspects, to chemically-modified double stranded nucleic acid molecules that are directed against a gene encoding T cell Immunoreceptor with Ig and ITIM domains (TIGIT).
    Type: Application
    Filed: August 4, 2022
    Publication date: September 12, 2024
    Applicant: Phio Pharmaceuticals Corp.
    Inventors: Melissa Maxwell, James Cardia, Simon Fricker
  • TOPICAL DELIVERY OF NUCLEIC ACID COMPOUNDS
    Publication number: 20200085764
    Abstract: In some aspects, the disclosure relates to RNAi constructs with improved tissue and cellular uptake characteristics and methods of use of these compounds in dermal applications.
    Type: Application
    Filed: April 19, 2018
    Publication date: March 19, 2020
    Applicant: Phio Pharmaceuticals Corp.
    Inventors: Melissa Maxwell, Richard J. Looby